TYK82 - Revision history

WikiSysop at 23:39, 23 January 2022

2022-01-23T23:39:11Z

← Older revision		Revision as of 23:39, 23 January 2022
Line 17:		Line 17:
	==Notes==		==Notes==
	<references />		<references />
	Shanberge, J. N., et al. "Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures." American Journal of Clinical Pathology 87.2 (1987): 210-217.		[https://academic.oup.com/ajcp/article-abstract/87/2/210/1785781 Shanberge, J. N., et al. "Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures." American Journal of Clinical Pathology 87.2 (1987): 210-217.]
	==Keywords==		==Keywords==

WikiSysop at 23:37, 23 January 2022

2022-01-23T23:37:23Z

← Older revision		Revision as of 23:37, 23 January 2022
Line 1:		Line 1:
	__NOTOC__		__NOTOC__
	~~<div class="mw-collapsible mw-collapsed" style="width:100%">~~
	Excess protamine is known to have anticoagulant effects. All of the following are true concerning the effects of excessive protamine EXCEPT:		Excess protamine is known to have anticoagulant effects. All of the following are true concerning the effects of excessive protamine EXCEPT:

Line 10:		Line 9:

	D. Reduced ADP-induced platelet aggregation		D. Reduced ADP-induced platelet aggregation
			<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div>
			<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer">
	<div class="mw-collapsible-~~content~~">
	==Answer==		==Answer==
	The answer is C.		The answer is C.

	Protamine causes all of the following will cause INCREASED (not decreased) fibrinolysis. Excess protamine will cause an elevation in the ACT, decreased platelet aggregation (specifically reduced ADP-induced aggregation) and increased fibrinolysis. These effects of protamine will alter the clot formation kinetics which will be evident on a TEG analysis. This will result in a decrease in the the alpha angle and maximum amplitude. Studies have suggested that the heparin-protamine complexes may reduce expression of P-selectin and/or reduce calcium utilization by platelets thereby reducing platelet aggregation. Protamine may also directly affect platelet function and inhibit tissue factor induced thrombin generation.<ref>Griffin, Michael J., et al. "The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress." Anesthesia & Analgesia 93.1 (2001): 20-27.[http://ovidsp.tx.ovid.com/sp-3.15.1b/ovidweb.cgi?&S=PPGGFPFEFCDDBMLINCKKNAFBFLNIAA00&Link+Set=S.sh.22.23.27.37%7c5%7csl_10]</ref>.		Protamine causes all of the following will cause INCREASED (not decreased) fibrinolysis. Excess protamine will cause an elevation in the ACT, decreased platelet aggregation (specifically reduced ADP-induced aggregation) and increased fibrinolysis. These effects of protamine will alter the clot formation kinetics which will be evident on a TEG analysis. This will result in a decrease in the the alpha angle and maximum amplitude. Studies have suggested that the heparin-protamine complexes may reduce expression of P-selectin and/or reduce calcium utilization by platelets thereby reducing platelet aggregation. Protamine may also directly affect platelet function and inhibit tissue factor induced thrombin generation.<ref>Griffin, Michael J., et al. "The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress." Anesthesia & Analgesia 93.1 (2001): 20-27.[http://ovidsp.tx.ovid.com/sp-3.15.1b/ovidweb.cgi?&S=PPGGFPFEFCDDBMLINCKKNAFBFLNIAA00&Link+Set=S.sh.22.23.27.37%7c5%7csl_10]</ref>.


	==Notes==		==Notes==
	<references />		<references />


	Shanberge, J. N., et al. "Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures." American Journal of Clinical Pathology 87.2 (1987): 210-217.		Shanberge, J. N., et al. "Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures." American Journal of Clinical Pathology 87.2 (1987): 210-217.

	==Keywords==		==Keywords==
	:


	</div>		</div>

	----		----
	----		----

WikiSysop: 1 revision imported

2021-03-20T16:48:32Z

1 revision imported

← Older revision	Revision as of 16:48, 20 March 2021
(No difference)

https://pedsanesthesia.net/wikiOLD032021>DrBobGreenberg at 22:51, 1 May 2015

2015-05-01T22:51:41Z

New page

__NOTOC__
<div class="mw-collapsible mw-collapsed" style="width:100%">
Excess protamine is known to have anticoagulant effects. All of the following are true concerning the effects of excessive protamine EXCEPT:

A. An elevation in ACT

B. Altered platelet aggregation

C. Decreased fibrinolysis

D. Reduced ADP-induced platelet aggregation

<div class="mw-collapsible-content">
==Answer==
The answer is C.

Protamine causes all of the following will cause INCREASED (not decreased) fibrinolysis. Excess protamine will cause an elevation in the ACT, decreased platelet aggregation (specifically reduced ADP-induced aggregation) and increased fibrinolysis. These effects of protamine will alter the clot formation kinetics which will be evident on a TEG analysis. This will result in a decrease in the the alpha angle and maximum amplitude. Studies have suggested that the heparin-protamine complexes may reduce expression of P-selectin and/or reduce calcium utilization by platelets thereby reducing platelet aggregation. Protamine may also directly affect platelet function and inhibit tissue factor induced thrombin generation.<ref>Griffin, Michael J., et al. "The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress." Anesthesia & Analgesia 93.1 (2001): 20-27.[http://ovidsp.tx.ovid.com/sp-3.15.1b/ovidweb.cgi?&S=PPGGFPFEFCDDBMLINCKKNAFBFLNIAA00&Link+Set=S.sh.22.23.27.37%7c5%7csl_10]</ref>.

==Notes==
<references />

Shanberge, J. N., et al. "Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures." American Journal of Clinical Pathology 87.2 (1987): 210-217.

==Keywords==
:

</div>

----
----

<p style="text-align: center;">[[TYK81|<Prev Question]] --- [[TYK83|Next Question>]]</p>
<p style="text-align: center;">[[TYK About | About Test Your Knowledge]]</p>